PharmAthene to Host Year-End 2007 Earnings Conference Call and Webcast on Thursday, March 20, 2008

Friday, March 14, 2008 General News J E 4
ANNAPOLIS, Md., March 13 PharmAthene, Inc.(Amex: PIP) a biodefense company developing medical countermeasures againstbiological and chemical threats, announced today that its financial resultsfor the year ended 2007 will be released on Thursday, March 20, 2008.

PharmAthene management will be hosting a conference call to discuss itsyear end financial results. The call is scheduled to begin at 4:30 p.m.Eastern Time on Thursday, March 20, 2008 and will last approximately 45minutes.

The dial-in number within the United States is 800-561-2813. The dial-innumber for international callers is 617-614-3529. The participant passcode is25398564.

A replay of the conference call will be available for 30 days, beginningat approximately 6:30 p.m. Eastern Time Thursday, March 20, 2008 untilapproximately 11:50 p.m. Eastern Time April 17, 2008. The dial-in number fromwithin the United States is 888-286-8010. For international callers, thedial-in number is 617-801-6888. The participant passcode is 99739488.

The conference call will also be webcast and can be accessed from thecompany's website at A link to the webcast may befound on both the Home Page and also under the Investor Relations section ofthe website. The webcast will be available for 30 days, or untilapproximately Thursday, April 17, 2008.

About PharmAthene, Inc

PharmAthene (Amex: PIP) was formed to meet the critical needs of theUnited States and its allies by developing and commercializing medicalcountermeasures against biological and chemical weapons. PharmAthene's leadprograms include Valortim(TM) for the prevention and treatment of anthraxinfection and Protexia(R) for the prevention and treatment of morbidity andmortality associated with exposure to chemical nerve agents. For moreinformation on PharmAthene, please visit

SOURCE PharmAthene, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The Healthplace America(TM) Benefit Delivers a Bet...
The Endovascular Forum Announces Partnerships with...